Bowel Cleansing Clinical Trial
Official title:
LINE Re-education Before Colonoscopy to Confirm Optimal Bowel Cleansing: A Prospective, Colonoscopist-blinded, Randomized, Controlled Trial
This is a prospective, colonoscopist-blinded, randomized, controlled study with consecutive outpatients undergoing colonoscopy in Taipei Medical University Hospital.The study would comply with the standards of the Declaration of Helsinki and current ethical guidelines. It have been approval by Taipei Medical University Institutional Review Board.
Written informed consent will be obtained from all the patients. Patients will be randomized to either the LINE re-education or control group for colon preparation at the time of appointment for colonoscopy by using consecutively numbered envelopes that will contain the treatment assignments, which will be generated by a computer-allocated random digit number, in a 1:1 ratio. At least two LINE accounts for all patients or their relatives living together will be recorded in case of failure to contact. All patients will be instructed not to tell colonoscopists, nurses and investigators before, during and after the procedure about their preparation method and when they receive instructions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02630680 -
Eziclen Drug Utilisation in Real Life Setting
|
||
| Completed |
NCT05032794 -
Unrestricted Diet for Screening Colonoscopy
|
N/A | |
| Completed |
NCT02239692 -
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
|
Phase 3 | |
| Unknown status |
NCT01481714 -
Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies
|
Phase 4 | |
| Completed |
NCT02321462 -
Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy
|
Phase 3 | |
| Completed |
NCT01864915 -
Prucalopride + Prucalopride Booster vs. Prucalopride + Picosalax Booster for the Colon Capsule
|
Phase 3 | |
| Completed |
NCT03631446 -
Drug Use-Results Survey on Picoprep® Combination Powder
|
||
| Recruiting |
NCT05354609 -
DWI MR-enterography Without or With Bowel Cleansing to Assess Intestinal Inflammatory Activity in the Follow-up of Crohn's Disease
|
N/A | |
| Completed |
NCT04852120 -
Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population
|